Profile
Dagmar Rosa-Bjorkeson currently works at New Jersey City University Foundation, as Director and Deirdres House, as Director.
Ms. Rosa-Bjorkeson also formerly worked at Intercept Pharmaceuticals, Inc., as Independent Director from 2021 to 2023, Xencor, Inc., as Independent Director from 2019 to 2025, Baxalta, Inc., as President-Biosimilars & EVP from 2014 to 2016, Novartis Pharmaceuticals Corp., as Vice President & Head-Multiple Sclerosis Business from 1997 to 2014, Hoechst Pharmaceuticals Ltd., as Sales Representative, Mallinckrodt Medical, Inc. (US), as Executive VP, Chief Strategy & Development Officer from 2017 to 2020, Novartis Sverige AB, as President, Mallinckrodt Plc, as Chief Strategy & Corporate Development Officer from 2018 to 2020, and Mesoblast Ltd., as Chief Operating Officer from 2020 to 2024.
Ms. Rosa-Bjorkeson received her undergraduate degree, graduate degree, and Masters Business Admin degree from The University of Texas at Austin.
Dagmar Rosa-Bjorkeson active positions
| Companies | Position | Start |
|---|---|---|
Deirdres House | Director/Board Member | - |
New Jersey City University Foundation
New Jersey City University Foundation Other Consumer ServicesConsumer Services Operates colleges and educational universities | Director/Board Member | - |
Former positions of Dagmar Rosa-Bjorkeson
| Companies | Position | End |
|---|---|---|
| XENCOR, INC. | Director/Board Member | 2025-06-11 |
| MESOBLAST LIMITED | Chief Operating Officer | 2024-11-30 |
| INTERCEPT PHARMACEUTICALS, INC. | Director/Board Member | 2023-11-07 |
| MALLINCKRODT PLC | Corporate Officer/Principal | 2019-12-31 |
Mallinckrodt Medical, Inc. (US)
Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2019-12-31 |
Training of Dagmar Rosa-Bjorkeson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Xencor, Inc.
Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Keenova Therapeutics Plc
Keenova Therapeutics Plc Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Hoechst Pharmaceuticals Ltd. | |
Mallinckrodt Medical, Inc. (US)
Mallinckrodt Medical, Inc. (US) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
New Jersey City University Foundation
New Jersey City University Foundation Other Consumer ServicesConsumer Services Operates colleges and educational universities | Consumer Services |
Deirdres House |
- Stock Market
- Insiders
- Dagmar Rosa-Bjorkeson
















